Medical - Healthcare Plans
Compare Stocks
2 / 10Stock Comparison
ALHC vs CNC
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
ALHC vs CNC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Market Cap | $3.74B | $26.15B |
| Revenue (TTM) | $4.26B | $198.10B |
| Net Income (TTM) | $20M | $-6.44B |
| Gross Margin | 9.0% | 14.9% |
| Operating Margin | 0.8% | -3.7% |
| Forward P/E | 141.3x | 15.7x |
| Total Debt | $338M | $18.78B |
| Cash & Equiv. | $578M | $17.89B |
ALHC vs CNC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Alignment Healthcar… (ALHC) | 100 | 83.4 | -16.6% |
| Centene Corporation (CNC) | 100 | 82.9 | -17.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALHC vs CNC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALHC carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 46.1%, EPS growth 99.4%, 3Y rev CAGR 40.2%
- 46.1% revenue growth vs CNC's 19.4%
- Combined ratio 1.0 vs CNC's 1.0 (lower = better underwriting)
CNC is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 0.39
- 74.6% 10Y total return vs ALHC's 5.7%
- Lower volatility, beta 0.39, Low D/E 93.6%, current ratio 1.68x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 46.1% revenue growth vs CNC's 19.4% | |
| Value | Lower P/E (15.7x vs 141.3x) | |
| Quality / Margins | Combined ratio 1.0 vs CNC's 1.0 (lower = better underwriting) | |
| Stability / Safety | Beta 0.39 vs ALHC's 0.75, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +18.2% vs CNC's -11.4% | |
| Efficiency (ROA) | 1.8% ROA vs CNC's -7.9% |
ALHC vs CNC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ALHC vs CNC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ALHC leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CNC is the larger business by revenue, generating $198.1B annually — 46.5x ALHC's $4.3B. Profitability is closely matched — net margins range from 0.5% (ALHC) to -3.3% (CNC). On growth, ALHC holds the edge at +33.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $4.3B | $198.1B |
| EBITDAEarnings before interest/tax | $66M | -$5.9B |
| Net IncomeAfter-tax profit | $20M | -$6.4B |
| Free Cash FlowCash after capex | $237M | $6.3B |
| Gross MarginGross profit ÷ Revenue | +9.0% | +14.9% |
| Operating MarginEBIT ÷ Revenue | +0.8% | -3.7% |
| Net MarginNet income ÷ Revenue | +0.5% | -3.3% |
| FCF MarginFCF ÷ Revenue | +5.6% | +3.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +33.3% | +7.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.1% | +18.3% |
Valuation Metrics
CNC leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.7B | $26.2B |
| Enterprise ValueMkt cap + debt − cash | $3.5B | $27.0B |
| Trailing P/EPrice ÷ TTM EPS | -4945.95x | -3.89x |
| Forward P/EPrice ÷ next-FY EPS est. | 141.31x | 15.70x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 77.35x | — |
| Price / SalesMarket cap ÷ Revenue | 0.95x | 0.13x |
| Price / BookPrice ÷ Book value/share | 20.21x | 1.30x |
| Price / FCFMarket cap ÷ FCF | 33.04x | 6.05x |
Profitability & Efficiency
ALHC leads this category, winning 6 of 7 comparable metrics.
Profitability & Efficiency
ALHC delivers a 11.5% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-29 for CNC. CNC carries lower financial leverage with a 0.94x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALHC's 1.89x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +11.5% | -28.6% |
| ROA (TTM)Return on assets | +1.8% | -7.9% |
| ROICReturn on invested capital | — | -21.6% |
| ROCEReturn on capital employed | +2.9% | -14.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 |
| Debt / EquityFinancial leverage | 1.89x | 0.94x |
| Net DebtTotal debt minus cash | -$240M | $889M |
| Cash & Equiv.Liquid assets | $578M | $17.9B |
| Total DebtShort + long-term debt | $338M | $18.8B |
| Interest CoverageEBIT ÷ Interest expense | 1.27x | -9.03x |
Total Returns (Dividends Reinvested)
Evenly matched — ALHC and CNC each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CNC five years ago would be worth $8,112 today (with dividends reinvested), compared to $6,806 for ALHC. Over the past 12 months, ALHC leads with a +18.2% total return vs CNC's -11.4%. The 3-year compound annual growth rate (CAGR) favors ALHC at 38.5% vs CNC's -8.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -9.5% | +26.8% |
| 1-Year ReturnPast 12 months | +18.2% | -11.4% |
| 3-Year ReturnCumulative with dividends | +165.6% | -22.6% |
| 5-Year ReturnCumulative with dividends | -31.9% | -18.9% |
| 10-Year ReturnCumulative with dividends | +5.7% | +74.6% |
| CAGR (3Y)Annualised 3-year return | +38.5% | -8.2% |
Risk & Volatility
CNC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CNC is the less volatile stock with a 0.39 beta — it tends to amplify market swings less than ALHC's 0.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CNC currently trades 82.6% from its 52-week high vs ALHC's 76.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.75x | 0.39x |
| 52-Week HighHighest price in past year | $23.87 | $64.15 |
| 52-Week LowLowest price in past year | $11.63 | $25.08 |
| % of 52W HighCurrent price vs 52-week peak | +76.7% | +82.6% |
| RSI (14)Momentum oscillator 0–100 | 42.6 | 83.9 |
| Avg Volume (50D)Average daily shares traded | 3.6M | 5.7M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates ALHC as "Buy" and CNC as "Buy". Consensus price targets imply 35.7% upside for ALHC (target: $25) vs -3.7% for CNC (target: $51).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $24.83 | $51.00 |
| # AnalystsCovering analysts | 16 | 43 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.8% |
ALHC leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CNC leads in 2 (Valuation Metrics, Risk & Volatility). 1 tied.
ALHC vs CNC: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is ALHC or CNC a better buy right now?
For growth investors, Alignment Healthcare, Inc.
(ALHC) is the stronger pick with 46. 1% revenue growth year-over-year, versus 19. 4% for Centene Corporation (CNC). Analysts rate Alignment Healthcare, Inc. (ALHC) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ALHC or CNC?
Over the past 5 years, Centene Corporation (CNC) delivered a total return of -18.
9%, compared to -31. 9% for Alignment Healthcare, Inc. (ALHC). Over 10 years, the gap is even starker: CNC returned +74. 6% versus ALHC's +5. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ALHC or CNC?
By beta (market sensitivity over 5 years), Centene Corporation (CNC) is the lower-risk stock at 0.
39β versus Alignment Healthcare, Inc. 's 0. 75β — meaning ALHC is approximately 91% more volatile than CNC relative to the S&P 500. On balance sheet safety, Centene Corporation (CNC) carries a lower debt/equity ratio of 94% versus 189% for Alignment Healthcare, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — ALHC or CNC?
By revenue growth (latest reported year), Alignment Healthcare, Inc.
(ALHC) is pulling ahead at 46. 1% versus 19. 4% for Centene Corporation (CNC). On earnings-per-share growth, the picture is similar: Alignment Healthcare, Inc. grew EPS 99. 4% year-over-year, compared to -315. 8% for Centene Corporation. Over a 3-year CAGR, ALHC leads at 40. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ALHC or CNC?
Alignment Healthcare, Inc.
(ALHC) is the more profitable company, earning -0. 0% net margin versus -3. 4% for Centene Corporation — meaning it keeps -0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALHC leads at 0. 4% versus -3. 9% for CNC. At the gross margin level — before operating expenses — ALHC leads at 12. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is ALHC or CNC more undervalued right now?
On forward earnings alone, Centene Corporation (CNC) trades at 15.
7x forward P/E versus 141. 3x for Alignment Healthcare, Inc. — 125. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALHC: 35. 7% to $24. 83.
07Which pays a better dividend — ALHC or CNC?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is ALHC or CNC better for a retirement portfolio?
For long-horizon retirement investors, Centene Corporation (CNC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
39)). Both have compounded well over 10 years (CNC: +74. 6%, ALHC: +5. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between ALHC and CNC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.